Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stephens

Showing results (981-990 of 1,072) with videos related to

Pageof 108
Sort By:
The American Journal of Surgical Pathology|January 15, 2014
Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapiesJeffrey S Ross, Kai Wang, Janna V Rand, et al.
JAMA Pediatrics|May 24, 2021
Effect of Training Pediatric Clinicians in Human Papillomavirus Communication Strategies on Human Papillomavirus Vaccination Rates: A Cluster Randomized Clinical TrialPeter G Szilagyi, Sharon G Humiston, Alisa J Stephens-Shields, et al.
British Journal of Pharmacology|April 14, 2026
Updated BJP guidelines for transparent and rigorous natural product researchXin Wang, Tayyiba Azam, Stephen P H Alexander, et al.
Journal of Hematology & Oncology|June 12, 2015
STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusionVivek Subbiah, Caitlin McMahon, Shreyaskumar Patel, et al.
Cancer|October 20, 2015
Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapiesRami N Al-Rohil, Ashley J Tarasen, J Andrew Carlson, et al.
Cancer Cell|March 22, 2016
Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2Scott A Foster, Daniel M Whalen, Ayşegül Özen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 9, 2018
Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLCJonathan W Riess, David R Gandara, Garrett M Frampton, et al.
The Journal of Urology|October 7, 2018
Comparative Genomic Profiling of Refractory and Metastatic Penile and Nonpenile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic TherapyJoseph M Jacob, Elizabeth K Ferry, Laurie M Gay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2015
Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencingC H Chung, V B Guthrie, D L Masica, et al.
Plos One|November 28, 2018
Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLCMichael E Goldberg, Meagan Montesion, Lauren Young, et al.
Pageof 108

Showing results (981-990 of 1,072) with videos related to

Sort By:
Pageof 108
The American Journal of Surgical Pathology|January 15, 2014
Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapiesJeffrey S Ross, Kai Wang, Janna V Rand, et al.
JAMA Pediatrics|May 24, 2021
Effect of Training Pediatric Clinicians in Human Papillomavirus Communication Strategies on Human Papillomavirus Vaccination Rates: A Cluster Randomized Clinical TrialPeter G Szilagyi, Sharon G Humiston, Alisa J Stephens-Shields, et al.
British Journal of Pharmacology|April 14, 2026
Updated BJP guidelines for transparent and rigorous natural product researchXin Wang, Tayyiba Azam, Stephen P H Alexander, et al.
Journal of Hematology & Oncology|June 12, 2015
STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusionVivek Subbiah, Caitlin McMahon, Shreyaskumar Patel, et al.
Cancer|October 20, 2015
Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapiesRami N Al-Rohil, Ashley J Tarasen, J Andrew Carlson, et al.
Cancer Cell|March 22, 2016
Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2Scott A Foster, Daniel M Whalen, Ayşegül Özen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 9, 2018
Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLCJonathan W Riess, David R Gandara, Garrett M Frampton, et al.
The Journal of Urology|October 7, 2018
Comparative Genomic Profiling of Refractory and Metastatic Penile and Nonpenile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic TherapyJoseph M Jacob, Elizabeth K Ferry, Laurie M Gay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2015
Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencingC H Chung, V B Guthrie, D L Masica, et al.
Plos One|November 28, 2018
Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLCMichael E Goldberg, Meagan Montesion, Lauren Young, et al.
Pageof 108